Site search
2807 results for '' found
An Open-Label, Phase 2a/2b Study of KRT-232 in Subjects With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (Post-PV-MF), Or Post–Essential Thrombocythemia MF (Post–ET-MF) Who Have Failed
An Open-Label, Phase 2a/2b Study of KRT-232 in Subjects With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (Post-PV-MF), Or Post–Essential Thrombocythemia MF (Post–ET-MF) Who Have Failed
/research/clinical-trials/find-clinical-trials/an-open-label-phase-2a-2b-study-of-krt-232-in-subjects-with-primary-myelofibrosis-pmf-postpolycythemia-vera-mf-post-pv-mf-or-postessential-thrombocythemia-mf-postet-mf-who-have-failed
Ketamine Sedation in Acute Traumatic Brain Injury: A Randomised Pilot Feasibility Study (ACTRN12623000594628)
Ketamine Sedation in Acute Traumatic Brain Injury: A Randomised Pilot Feasibility Study (ACTRN12623000594628)
/research/clinical-trials/find-clinical-trials/ketamine-sedation-in-acute-traumatic-brain-injury-a-randomised-pilot-feasibility-study-actrn12623000594628
A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complet
A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complet
/research/clinical-trials/find-clinical-trials/a-phase-3-double-blinded-two-arm-study-to-evaluate-the-safety-and-efficacy-of-pembrolizumab-mk-3475-versus-placebo-as-adjuvant-therapy-in-participants-with-hepatocellular-carcinoma-and-complet
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally A
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally A
/research/clinical-trials/find-clinical-trials/a-phase-3-randomized-double-blind-placebo-controlled-study-to-evaluate-pembrolizumab-versus-placebo-as-adjuvant-therapy-following-surgery-and-radiation-in-participants-with-high-risk-locally-a
The Keto eCoach Program: a multimodality digital health intervention to aid the delivery of ketogenic diet therapy for epilepsy (ACTRN12624000486527)
The Keto eCoach Program: a multimodality digital health intervention to aid the delivery of ketogenic diet therapy for epilepsy (ACTRN12624000486527)
/research/clinical-trials/find-clinical-trials/the-keto-ecoach-program-a-multimodality-digital-health-intervention-to-aid-the-delivery-of-ketogenic-diet-therapy-for-epilepsy-actrn12624000486527
A Randomised, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arteria
A Randomised, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arteria
/research/clinical-trials/find-clinical-trials/a-randomised-phase-2-double-blind-placebo-controlled-study-to-investigate-the-safety-and-efficacy-of-ker-012-in-combination-with-background-therapy-in-adult-participants-with-pulmonary-arteria
A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participa
A Randomized, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Idecabtagene Vicleucel with Lenalidomide Maintenance Versus Lenalidomide Maintenance Therapy Alone in Adult Participa
/research/clinical-trials/find-clinical-trials/a-randomized-open-label-phase-3-trial-to-compare-the-efficacy-and-safety-of-idecabtagene-vicleucel-with-lenalidomide-maintenance-versus-lenalidomide-maintenance-therapy-alone-in-adult-participa
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squa
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to evaluate Dostarlimab as Sequential Therapy after Chemoradiation in Participants with Locally Advanced Unresected Head and Neck Squa
/research/clinical-trials/find-clinical-trials/a-randomized-double-blind-placebo-controlled-phase-3-study-to-evaluate-dostarlimab-as-sequential-therapy-after-chemoradiation-in-participants-with-locally-advanced-unresected-head-and-neck-squa
A Phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma
A Phase 3, open-label, randomized 2-arm study comparing the clinical efficacy and safety of niraparib with temozolomide in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma
/research/clinical-trials/find-clinical-trials/a-phase-3-open-label-randomized-2-arm-study-comparing-the-clinical-efficacy-and-safety-of-niraparib-with-temozolomide-in-adult-participants-with-newly-diagnosed-mgmt-unmethylated-glioblastoma
A Randomised Double-blind Placebo-controlled Pilot Study of Intravenous Immunoglobulin Replacement Therapy in Lung Transplantation (ACTRN12618001394235)
A Randomised Double-blind Placebo-controlled Pilot Study of Intravenous Immunoglobulin Replacement Therapy in Lung Transplantation (ACTRN12618001394235)
/research/clinical-trials/find-clinical-trials/a-randomised-double-blind-placebo-controlled-pilot-study-of-intravenous-immunoglobulin-replacement-therapy-in-lung-transplantation-actrn12618001394235